Engine Biosciences is a venture-backed technology company integrating experimental biology and data science to map and decipher complex biological networks for more effective and efficient drug discovery.
Engine’s technologies culminate from several years of research by our scientific founders and leaders who comprise faculty members of MIT, Harvard, Mayo Clinic, and UCSD, and our leadership team is applying our previous successful company building experiences to Engine to advance treatments to patients faster.
Applications of our broad platform include rational combination therapy development, drug repurposing, novel drug discovery, and precision medicine enablement, and we have published proof-of-concept results in leading peer-reviewed journals (Science, Cell, Nature Biotechnology, PNAS, and others). Engine is actively working in a range of indications through both internal work and partnerships with Fortune 500 companies and leading research institutions in USA and Asia.
We are based in San Francisco and in Singapore.
Asha is one of the earliest employees of Engine Bio, driving various scientific and drug discovery projects within the company. She is a skilled scientist and biomedical engineering professional. She previously served as a Research Fellow in Singapore’s A*STAR, where she worked extensively on multidisciplinary projects involving stem cells for therapeutic uses and managed collaborations with companies and research groups. She has published papers in notable journals including PNAS, Nature Materials, Nature Nanotechnology, Bone, and Biomaterials.
Asha received her BSE (magna cum laude) from Northwestern University and her Ph.D. in Biomedical Engineering from Georgia Institute of Technology and Emory University. She has received several awards, including the STAR Award and multiple A*STAR National Science Scholar Fellowships from the Singapore government. She has lived in both the USA and Singapore.